Kyowa Kirin Co., Ltd.
4151----
Kyowa Kirin Co., Ltd. (4151)
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- prnewswire · Jul 9 at 09:31 AM
10:31 ETSystemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
- Simplywall · Jun 30 at 11:12 AM
How Investors Are Reacting To Kyowa Kirin (TSE:4151) Real-World Data On Mogamulizumab’s Patient Benefits
- QQ News · Jun 26 at 03:23 AM
Weijian Pharmaceutical re-enters the Hong Kong Stock Exchange: A story of specialty kidney disease drugs supported by an acquisition
- StockTitan · Jun 10 at 11:02 PM
Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML | KURA Stock News
- StockTitan · Jun 1 at 11:32 PM
Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML | KURA Stock News
- Simplywall · May 17 at 05:07 AM
Is Kyowa Kirin (TSE:4151) Pricing Reflect Its Mixed Long Term Share Performance
